Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,194 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

NCT03349060

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Rady Children's Hospital - San Diego/University of California, San Diego San Diego, California, United States
  • TCR Medical Corporation San Diego, California, United States
View all 88 locations
View Trial Details
Completed

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

NCT03100344

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Galderma Investigational site Birmingham, Alabama, United States
  • Galderma Investigational site Fort Smith, Arkansas, United States
  • Galderma Investigational site Beverly Hills, California, United States
  • Galderma Investigational site Fountain Valley, California, United States
View all 67 locations
View Trial Details
Completed

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

NCT03356977

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Rady Children's Hospital - San Diego/University of California, San Diego San Diego, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 32 locations
View Trial Details
Completed

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

NCT03269773

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Pusan National University Hospital Busan, South Korea
  • Chonnam National University Hospital Gwangju, South Korea
  • Dongguk University Medical Center Ilsan, South Korea
  • Gachon University Gil Medical Center Incheon, South Korea
View Trial Details

Related conditions